1.26
전일 마감가:
$1.26
열려 있는:
$1.26
하루 거래량:
46,749
Relative Volume:
0.19
시가총액:
$160.33M
수익:
-
순이익/손실:
$-12.84M
주가수익비율:
-11.02
EPS:
-0.1143
순현금흐름:
$-8.76M
1주 성능:
+0.00%
1개월 성능:
-10.00%
6개월 성능:
-30.77%
1년 성능:
-9.03%
Tiziana Life Sciences Ltd Stock (TLSA) Company Profile
Compare TLSA vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
TLSA
Tiziana Life Sciences Ltd
|
1.26 | 160.33M | 0 | -12.84M | -8.76M | -0.1143 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Tiziana Life Sciences Ltd Stock (TLSA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2020-12-22 | 개시 | B. Riley Securities | Buy |
| 2018-12-17 | 개시 | Laidlaw | Buy |
Tiziana Life Sciences Ltd 주식(TLSA)의 최신 뉴스
Large TLSA stake reported by director Gabriele M. Cerrone on Form 3 - Stock Titan
Macro Review: Is Tiziana Life Sciences Ltd subject to activist investor interest2026 Closing Moves & Weekly Sector Rotation Insights - baoquankhu1.vn
Forecast Cut: Can Tiziana Life Sciences Ltd maintain its current growth rate2026 Big Picture & Fast Moving Stock Watchlists - baoquankhu1.vn
Price Action: Can Tiziana Life Sciences Ltd be recession proofTrade Risk Report & High Accuracy Investment Signals - baoquankhu1.vn
TLSA Earnings History & Surprises | EPS & Revenue Results | TIZIANA LIFE SCIENCES LTD (NASDAQ:TLSA) - ChartMill
Tiziana Life Sciences (NASDAQ:TLSA) Stock Price Down 4.4%Should You Sell? - MarketBeat
Tiziana Life Sciences (TLSA) Stock Analysis Report | Financials & Insights - Benzinga Japan
Whats next for Tiziana Life Sciences Ltd stockAnalyst Upgrade & Real-Time Volume Trigger Notifications - baoquankhu1.vn
New Highs: Can Tiziana Life Sciences Ltd expand its profit margins2026 Sector Moves & Fast Gaining Stock Reports - baoquankhu1.vn
Aug Macro: Is Tiziana Life Sciences Ltd a stock for growth or value investorsMarket Performance Summary & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
Day Trade: Can Tiziana Life Sciences Ltd maintain its current growth rate2025 Volume Leaders & Momentum Based Trading Ideas - baoquankhu1.vn
Market movers: Circle Internet Group, Tiziana Life Sciences, Cava, Lowe’s… - Proactive Investors
Tiziana reports biomarker gains for nasal MS therapy in progressive disease - Yahoo
Tiziana Life Sciences PLC (TLSA) announces new biomarker data - Bitget
Tiziana Life Sciences Posts Positive Biomarker Data for Intranasal Foralumab in Progressive MS - TipRanks
Tiziana Life Sciences Announces New Biomarker Data Showing Nasal Foralumab Downregulates CSF Inflammation, Upregulates Neuroprotective Pathways, and Correlates with Reduced Microglial Activation on PET Scans in na-SPMS Patients with PIRA - The Manila Times
New foralumab biomarker data in na-SPMS from Tiziana (Nasdaq: TLSA) - Stock Titan
Tiziana Life Sciences Ltd. - Via Ritzau
What’s next for Tiziana Life Sciences Ltd stockIndex Update & Safe Capital Growth Stock Tips - mfd.ru
Tiziana Life Sciences (NASDAQ:TLSA) Trading Up 0.7%Here's What Happened - MarketBeat
Does Tiziana Life Sciences Ltd outperform in volatile markets2025 Growth vs Value & Short-Term Trading Alerts - mfd.ru
What is Tiziana Life Sciences Ltd s 5 year growth outlookM&A Rumor & Smart Allocation Stock Reports - mfd.ru
TLSA PE Ratio & Valuation, Is TLSA Overvalued - Intellectia AI
TLSA Should I Buy - Intellectia AI
Is Tiziana Life Sciences Ltd stock affected by interest rate hikesPortfolio Value Report & Risk Adjusted Buy and Sell Alerts - mfd.ru
How Tiziana Life Sciences Ltd stock reacts to Fed rate cutsWeekly Trading Summary & Free Expert Verified Stock Movement Alerts - mfd.ru
Is Tiziana Life Sciences Ltd in a consolidation phaseEarnings Miss & Weekly High Potential Stock Alerts - mfd.ru
Can Tiziana Life Sciences Ltd sustain earnings growth2025 Trade Ideas & Safe Capital Growth Stock Tips - mfd.ru
Investment Review: Is Tiziana Life Sciences Ltd stock overvalued or fairly priced2025 Macro Impact & Short-Term High Return Ideas - baoquankhu1.vn
Profit Review: Is Tiziana Life Sciences Ltd a stock for growth or value investors2025 Volume Leaders & AI Optimized Trade Strategies - baoquankhu1.vn
What are the future prospects of MAIA Biotechnology IncSwing Trade & Daily Technical Forecast Reports - baoquankhu1.vn
Income Plays: What are the future prospects of Tiziana Life Sciences Ltd2025 Breakouts & Breakdowns & Smart Investment Allocation Tips - baoquankhu1.vn
While insiders own 43% of Tiziana Life Sciences Ltd (NASDAQ:TLSA), individual investors are its largest shareholders with 53% ownership - Yahoo Finance
Earnings Update: Is Tiziana Life Sciences Ltd subject to activist investor interestTrade Exit Report & Precise Swing Trade Alerts - baoquankhu1.vn
Revenue Check: Is Tiziana Life Sciences Ltd subject to activist investor interestQuarterly Market Review & Free Accurate Trade Setup Notifications - baoquankhu1.vn
Market Recap: Is KRYS stock a value trap2025 Risk Factors & Verified Momentum Stock Alerts - baoquankhu1.vn
Can Tiziana Life Sciences Ltd expand its profit marginsWeekly Trade Summary & Reliable Breakout Forecasts - baoquankhu1.vn
Performance Recap: Can Tiziana Life Sciences Ltd maintain its current growth rate - baoquankhu1.vn
Breakout Zone: Will Tiziana Life Sciences Ltd outperform its industry peersInsider Selling & Weekly Watchlist of Top Performers - baoquankhu1.vn
Tiziana Life Sciences (NASDAQ:TLSA) Stock Price Up 3.1%Should You Buy? - MarketBeat
Pullback Watch: What are the future prospects of Tiziana Life Sciences LtdJuly 2025 EndofMonth & Verified Swing Trading Watchlist - baoquankhu1.vn
Market Recap: Does BHA have strong fundamentalsTrade Entry Summary & Short-Term High Return Ideas - baoquankhu1.vn
Tiziana's Intranasal Foralumab Study Results Published In Peer-Reviewed Journal - RTTNews
Tiziana Life Sciences Announces the Peer-Reviewed Publication of Clinical Study Results for Intranasal Foralumab - The Manila Times
Tiziana Life Sciences (TLSA) Reports Positive Results in MS Stud - GuruFocus
Tiziana Life Sciences publishes positive study on intranasal MS therapy - Proactive financial news
Tiziana Life Sciences Publishes Positive Results of Intranasal Foralumab Study for Non-Active Secondary Progressive Multiple Sclerosis - Quiver Quantitative
Experimental nasal MS antibody steadies disability in small study - Stock Titan
Small cap wrap: American Resources, Tiziana Life Sciences, Digi Power X, Midnight Sun Mining... - Proactive financial news
Tiziana Life Sciences Announces Registered Direct Offering of up to approximately $17.6 Million - marketscreener.com
History Review: Can Tiziana Life Sciences Ltd sustain earnings growthEarnings Risk Summary & High Accuracy Trade Alerts - baoquankhu1.vn
Tiziana Life Sciences Ltd (TLSA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):